Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
6.739 / 17.034
#53905

Re: Farmas USA

uso bno

ojo petroleo reunión importante, podemos estar en mínimos.

#53906

Re: Farmas USA

Reunión mañana 27, coincidiendo con el Día de Acción de Gracias (thanksgiving) y con el mercado USA cerrado.

Si alguién quiere hacer algo deberá esperar al viernes, pero como tienen que digerir bien el pavo, solo abierto hasta las 19h.

#53908

Re: Farmas USA

ONCS
http://finance.yahoo.com/news/oncs-results-newly-initiated-phase-140000517.html

Initiation of a landmark Phase II combination trial in collaboration with the UCSF and Merck to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 drug, KEYTRUDA® (pembrolizumab) in combination with OncoSec’s ImmunoPulse therapy (intratumoral IL- 12) for the treatment of metastatic melanoma patients, who are non-responsive to KEYTRUDA®

No puede pintar mejor. Precio objetivo sube de 2$ a 4$

¿alguien que aún las mantenga como yo?

#53912

Re: Farmas USA

Analyst Update on Short Term Price Target:Walgreen Company , Novavax Inc

http://www.marketsinsider.com/analyst-update-on-short-term-price-targetwalgreen-company-novavax-inc-2/321376/

 

Novavax Inc (NASDAQ:NVAX) shares are expected to touch $9.5 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 1.41. The target price could hit $11 on the higher end and $7 on the lower end. Novavax Inc (NASDAQ:NVAX) : Optimism-led buying helped Novavax Inc (NASDAQ:NVAX)post gains of 0.19% or 0.01 points. The mood remained fairly bullish throughout the day and no significant downmove or selling pressure was witnessed. During the day, the shares fluctuated in $5.17-$5.29 but finally closed higher at $5.26. The shares had closed the previous day trading session at $5.25. The 52-week high of Novavax Inc (NASDAQ:NVAX) is at $6.95. The volume for the day was recorded at 1,984,445 shares. Currently, there are 238,478,000 outstanding shares and the company has a market cap of $1,254 million. The 52-week low of the shares is at $3.33.

 

 

Me hace gracia lo del "short-term" ... que relativo es ja,ja

NVAX

 

edito: añado un grafico en MENSUAL de como vamos

esos 5,60 ... que cerca y que lejillos estan ahora ...